Abstract: A protein hydrolysate obtained from at least one protein source from bluefish having (i) a degree of hydrolysis (DH) of at least 10%, (ii) at least 80% water-soluble protein with a molecular weight of less than 1000 Da, (iii) at least 0.3% phospholipids, and (iv) at least 0.5% DHA and EPA.

Abstract: A method for removing a biofilm present on a substrate includes providing a detergent component comprising a sequestrant, a wetting agent and a dispersant, and an enzymatic component containing at least one protease, and at least one polysaccharidase in solution in an aqueous phase in sequence or simultaneously, and applying the solution to the substrate for a predetermined period of time to effect biofilm removal from the substrate.

Abstract: A process for producing magnesia can include contacting CO2-containing emissions with a magnesium-containing material to produce magnesium carbonate; subjecting the magnesium carbonate to calcination to produce a CO2 by-product and magnesia; and recycling at least a portion of the CO2 by-product for contacting the magnesium-containing material to produce the magnesium carbonate. The magnesium-containing material can include mining residues, such as phyllosilicate or chrysotile mining residue, and the magnesium carbonate produced can include precipitated nesquehonite that is subjected to calcination to produce the magnesia.

Abstract: A method and a system for generating a time-frequency representation of an aperiodic continuous input signal comprising generating a periodic train of short pulses having a repetition frequency, and sampling the signal temporally using the periodic train of short pulses to obtain a temporally sampled signal, the temporally sampled signal comprising a plurality of sampled copies of the input signal, each sampled copy being spaced in function of the repetition frequency of the periodic train of short pulses. The temporally sampled signal is delayed based on the repetition frequency to obtain a delayed temporally sampled signal comprising a plurality of delayed sampled copies, a spectral representation of a given delayed sampled copy being delayed in function of the repetition frequency. The delayed temporally sampled signal is evaluated over consecutive time slots to obtain, for each consecutive time slot, a respective output signal in the time-frequency domain.

Abstract: Composition for the removal of biofilms present on a substrate, characterized in that it comprises at least one detergent component comprising a sequestrant and also a wetting agent and a dispersant and at least one enzymatic component containing at least one protease, at least one laccase and at least one polysaccharidase, method of implementation thereof and uses thereof.

Abstract: Described herein are biopesticides having activity against Erwinia species, particularly against the fire blight phytopathogen Erwinia amylovora. The biopesticides comprise intact or vegetative cells, endospores, spores, and/or metabolites from one or more bacterial species or strains as active ingredients, wherein the vegetative cells, endospores, spores, and/or metabolites exhibit antimicrobial activity against phytopathogenic Erwinia species or Erwinia amylovora.

Abstract: Apparatus to acquire an image of roots of a plant located in a target rhizotron. The apparatus includes: a turntable having a rotation axis and intended to support the target rhizotron; a lightening device; a first camera having an optical axis substantially oriented toward the rotation axis; a focus sensor arranged so as to provide a measure at least one parameter of the first camera; a control module, configured to receive the measure, compare the measure to comparison data, and inform an operator accordingly, the comparison data comprising data related to reference rhizotrons different than the target rhizotron, and/or data related to one or several previously acquired images of the target rhizotron.

Abstract: Agents that inhibit the dimerization of a prototypic galectin such as galectin-7 are described. These agents, for example antibodies and peptides, bind to a domain corresponding to residues 13-25, 86-108 and/or 129-135 of human galectin-7. The use of such agents to inhibit a biological, physiological and/or pathological process that involves prototypic galectin dimerization, for example for, the inhibition of galectin-7-mediated apoptosis and the treatment of galectin-7-expressing cancers, is also described.

Abstract: The invention relates to a method for separating, from a culture medium, an enzymatic cocktail and the fungus Trichoderma Reesei, the culture medium resulting from enzyme production by the fungus, method in which: said culture medium is subjected, in a period of no longer than 30 h from the halting of production, to a separation on a filter press lined with a fabric having a porosity of 3-20 ?m, so as to obtain a filtrate having a corrected optical density OD at 600 nm of less than 2.5; and the liquid phase obtained is subjected to tangenital micro-filtration on a ceramic membrane having a cut-off limit of 0.5 to 1.4 ?m, so that the corrected OD at 600 nm does not exceed 0.1.

Abstract: The invention concerns a nutritional or therapeutic agent comprising a molecule mix obtained from Vitis vinifera and Vaccinium angustifolium, comprising: at least 1% of catechins and epicatechins, the percentage being given by weight in relation to the total weight of the mix, preferably at least 5%, at least 5 ppm (parts per million in the mix) of ferulic acid, preferably at least 10 ppm. The invention also relates to the use of this agent due to its effects on cognitive functions in particular.

Abstract: There is described a system for lossless sampling and denoising amplification of a signal, comprising: a first phase modulator configured for receiving a wave signal and modulating a phase of the wave signal while satisfying a Talbot condition to obtain a sampled signal; and a second phase modulator configured for receiving the sampled signal, compensating for a given phase induced in the sampled signal by the first phase modulator while satisfying the Talbot condition to obtain a denoised and amplified signal, and outputting the denoised and amplified signal.

Abstract: The present invention relates to the field of crop fertilization, and particularly to a biofertilizing bacterial strain. In particular, the present invention relates to the bacterial strain deposited on Oct. 24, 2018, at the Collection Nationale de Culture de Microorganismes (CNCM), 28 rue du Dr. Roux, 75724 PARIS CEDEX 15, under the Budapest Treaty under number CNCM I-5372, and to the uses of this strain. The invention also relates to a composition comprising the above-mentioned bacterial strain and to a fertilization process comprising the application of this composition to a plant or to a soil.

Abstract: The present invention relates to the field of crop fertilization, and particularly to a biofertilizing bacterial strain. In particular, the present invention relates to the bacterial strain deposited on Oct. 24, 2018, at the Collection Nationale de Culture de Microorganismes (CNCM), 28 rue du Dr. Roux, 75724 PARIS CEDEX 15, under the Budapest Treaty under number CNCM I-5373, and to the uses of this strain. The invention also relates to a composition comprising the above-mentioned bacterial strain and to a fertilization process comprising the application of this composition to a plant or to a soil.

Abstract: The invention concerns a continuous method for treating a lignocellulosic biomass before enzymatic hydrolysis, said method comprising a transfer of crushed then pressed biomass to a step of impregnation by an acid liquor, the impregnated biomass dripping over the area containing the impregnation liquor, then the resulting wet biomass is pressed and sent to a steam explosion step. The impregnation liquor is prepared in a dedicated area from the used liquor from the dripping operation and/or that from the pressing operation, prior to the explosion step. The invention also concerns the facility for implementing the method.

Abstract: A process for producing polyhydroxyalkanoates (PHA) is provided. The process comprises: providing a waste stream comprising lignocellulosic materials; adding an calcium-containing mineral to the waste stream; heat-treating the waste stream in the presence of the calcium-containing mineral, to obtain a treated waste stream; fermenting at least one strain of PHA-producing microorganism in a culture medium comprising the treated waste stream as a carbon source, to produce the PHA; and extracting the PHA from the PHA-producing microorganism.

Abstract: The present invention relates to a process for treating lignocellulosic biomass, successively comprising b) a step of pretreatment of the biomass placed beforehand under acidic or neutral pH conditions in a pretreatment reactor (3), to produce an acidic or neutral pretreated must (AM), alternating with b?) a step of pretreatment of the biomass placed beforehand under acidic, neutral or basic conditions, with optional sufficient introduction of a basic aqueous solution (EB) into the pretreatment reactor (3) to produce a basic pretreated must (BM), and then c) a step of enzymatic hydrolysis in a hydrolysis reactor (16) of a mixture of the acidic or neutral pretreated must (AM) obtained from step b) with the basic pretreated must (BM) obtained from step b?).

Abstract: A composition including an extract of Moricandia for the use thereof in the prevention and/or treatment of metabolic diseases related to impaired glucose tolerance and/or insulin resistance. Also a composition including an extract of Moricandia for the use thereof in the prevention of weight gain, in particular of body fat.

Abstract: The invention relates to a novel bacterial strain deposited with the CNCM under number 1-4969. This strain has properties that are useful in the treatment of respiratory disorders. The invention also relates to compositions and uses of said strain.

Abstract: The present invention relates to a composition exhibiting a bile-salt hydrolase activity for its use for the treatment or the prevention of giardiasis, said composition comprising a bile-salt hydrolase (BSH)enzyme, a bacterium able to secrete a BSH, a recombinant host cell able to secrete a BSH, or a combination thereof. The present invention also relates to the use of a composition exhibiting a BSH activity for the treatment or the prevention of giardiasis, and to a pharmaceutical composition or a food composition comprising, as an active principle, a BSH, a lactic acid bacterium able to secrete a BSH, or a recombinant host cell able to secrete a BSH.

Abstract: The present disclosure relates to a stable copper-based core-shell nanoparticle and its process of manufacture. Further, the present disclosure relates to the use of the copper-based core-shell nanoparticles as plasmonic photocatalysts in photocalysis and hydrogen production.